195 related articles for article (PubMed ID: 10069460)
1. Characterization of cytochrome P450 expression in human oesophageal mucosa.
Lechevrel M; Casson AG; Wolf CR; Hardie LJ; Flinterman MB; Montesano R; Wild CP
Carcinogenesis; 1999 Feb; 20(2):243-8. PubMed ID: 10069460
[TBL] [Abstract][Full Text] [Related]
2. Comparative cytochrome P450 -1A1, -2A6, -2B6, -2C, -2D6, -2E1, -3A5 and -4B1 expressions in human larynx tissue analysed at mRNA level.
Sarikaya D; Bilgen C; Kamataki T; Topcu Z
Biopharm Drug Dispos; 2006 Nov; 27(8):353-9. PubMed ID: 16894644
[TBL] [Abstract][Full Text] [Related]
3. CYP2A6/2A7 and CYP2E1 expression in human oesophageal mucosa: regional and inter-individual variation in expression and relevance to nitrosamine metabolism.
Godoy W; Albano RM; Moraes EG; Pinho PR; Nunes RA; Saito EH; Higa C; Filho IM; Kruel CD; Schirmer CC; Gurski R; Lang MA; Pinto LF
Carcinogenesis; 2002 Apr; 23(4):611-6. PubMed ID: 11960914
[TBL] [Abstract][Full Text] [Related]
4. Rat oesophageal cytochrome P450 (CYP) monooxygenase system: comparison to the liver and relevance in N-nitrosodiethylamine carcinogenesis.
Pinto LF; Moraes E; Albano RM; Silva MC; Godoy W; Glisovic T; Lang MA
Carcinogenesis; 2001 Nov; 22(11):1877-83. PubMed ID: 11698352
[TBL] [Abstract][Full Text] [Related]
5. Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studies.
Kranendonk M; Carreira F; Theisen P; Laires A; Fisher CW; Rueff J; Estabrook RW; Vermeulen NP
Mutat Res; 1999 Apr; 441(1):73-83. PubMed ID: 10224324
[TBL] [Abstract][Full Text] [Related]
6. Rapid determination of rat hepatocyte mRNA induction potential using oligonucleotide probes for CYP1A1, 1A2, 3A and 4A1.
Surry DD; Meneses-Lorente G; Heavens R; Jack A; Evans DC
Xenobiotica; 2000 May; 30(5):441-56. PubMed ID: 10875679
[TBL] [Abstract][Full Text] [Related]
7. Expression of cytochrome P450 2A3 in rat esophagus: relevance to N-nitrosobenzylmethylamine.
Gopalakrishnan R; Morse MA; Lu J; Weghorst CM; Sabourin CL; Stoner GD; Murphy SE
Carcinogenesis; 1999 May; 20(5):885-91. PubMed ID: 10334207
[TBL] [Abstract][Full Text] [Related]
8. Induction of cytochrome P450 (CYP)1A1, CYP1A2, and CYP3A4 but not of CYP2C9, CYP2C19, multidrug resistance (MDR-1) and multidrug resistance associated protein (MRP-1) by prototypical inducers in human hepatocytes.
Runge D; Köhler C; Kostrubsky VE; Jäger D; Lehmann T; Runge DM; May U; Stolz DB; Strom SC; Fleig WE; Michalopoulos GK
Biochem Biophys Res Commun; 2000 Jun; 273(1):333-41. PubMed ID: 10873607
[TBL] [Abstract][Full Text] [Related]
9. Relationships between non-occupational cadmium exposure and expression of nine cytochrome P450 forms in human liver and kidney cortex samples.
Baker JR; Satarug S; Reilly PE; Edwards RJ; Ariyoshi N; Kamataki T; Moore MR; Williams DJ
Biochem Pharmacol; 2001 Sep; 62(6):713-21. PubMed ID: 11551516
[TBL] [Abstract][Full Text] [Related]
10. Role of human cytochrome P450 (CYP) in the metabolic activation of N-alkylnitrosamines: application of genetically engineered Salmonella typhimurium YG7108 expressing each form of CYP together with human NADPH-cytochrome P450 reductase.
Fujita K; Kamataki T
Mutat Res; 2001 Nov; 483(1-2):35-41. PubMed ID: 11600130
[TBL] [Abstract][Full Text] [Related]
11. Expression of cytochrome P450 enzymes CYP1A1, CYP1B1, CYP2E1 and CYP4B1 in cultured transitional cells from specimens of the human urinary tract and from urinary sediments.
Roos PH; Belik R; Föllmann W; Degen GH; Knopf HJ; Bolt HM; Golka K
Arch Toxicol; 2006 Jan; 80(1):45-52. PubMed ID: 16341845
[TBL] [Abstract][Full Text] [Related]
12. Induction and regulation of xenobiotic-metabolizing cytochrome P450s in the human A549 lung adenocarcinoma cell line.
Hukkanen J; Lassila A; Päivärinta K; Valanne S; Sarpo S; Hakkola J; Pelkonen O; Raunio H
Am J Respir Cell Mol Biol; 2000 Mar; 22(3):360-6. PubMed ID: 10696073
[TBL] [Abstract][Full Text] [Related]
13. Functional role of cytochrome p-450 2a3 in N-nitrosomethylbenzylamine metabolism in rat esophagus.
Gopalakrishnan R; Gupta A; Carlton PS; Morse MA; Stoner GD
J Toxicol Environ Health A; 2002 Aug; 65(15):1077-91. PubMed ID: 12167220
[TBL] [Abstract][Full Text] [Related]
14. Measurement of cytochrome P450 2A6 and 2E1 gene expression in primary human bronchial epithelial cells.
Crawford EL; Weaver DA; DeMuth JP; Jackson CM; Khuder SA; Frampton MW; Utell MJ; Thilly WG; Willey JC
Carcinogenesis; 1998 Oct; 19(10):1867-71. PubMed ID: 9806171
[TBL] [Abstract][Full Text] [Related]
15. Cytochromes P450 are expressed in proliferating cells in Barrett's metaplasia.
Hughes SJ; Morse MA; Weghorst CM; Kim H; Watkins PB; Guengerich FP; Orringer MB; Beer DG
Neoplasia; 1999 Jun; 1(2):145-53. PubMed ID: 10933049
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissues.
Macé K; Bowman ED; Vautravers P; Shields PG; Harris CC; Pfeifer AM
Eur J Cancer; 1998 May; 34(6):914-20. PubMed ID: 9797707
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of cytochrome P450 protein in non-malignant colonic tissue of patients with colonic adenoma.
Bergheim I; Bode C; Parlesak A
BMC Gastroenterol; 2005 Nov; 5():34. PubMed ID: 16281975
[TBL] [Abstract][Full Text] [Related]
18. The stimulatory role of human cytochrome b5 in the bioactivation activities of human CYP1A2, 2A6 and 2E1: a new cell expression system to study cytochrome P450 mediated biotransformation.
Duarte MP; Palma BB; Gilep AA; Laires A; Oliveira JS; Usanov SA; Rueff J; Kranendonk M
Mutagenesis; 2005 Mar; 20(2):93-100. PubMed ID: 15728263
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of cytochrome P450 enzymes in normal and tumor tissues from childhood rhabdomyosarcoma.
Molina-Ortiz D; Camacho-Carranza R; González-Zamora JF; Shalkow-Kalincovstein J; Cárdenas-Cardós R; Ností-Palacios R; Vences-Mejía A
PLoS One; 2014; 9(4):e93261. PubMed ID: 24699256
[TBL] [Abstract][Full Text] [Related]
20. Nasal cytochrome P450 2A: identification, regional localization, and metabolic activity toward hexamethylphosphoramide, a known nasal carcinogen.
Thornton-Manning JR; Nikula KJ; Hotchkiss JA; Avila KJ; Rohrbacher KD; Ding X; Dahl AR
Toxicol Appl Pharmacol; 1997 Jan; 142(1):22-30. PubMed ID: 9007030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
